Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ctDNA and MR Imaging Parameters as Possible Biomarkers in Primary Radiochemotherapy of Head and Neck Squamous Cell Carcinomas

NCT06215612 is registered in ClinicalTrials.gov with Franziska Eckert as lead sponsor.

NCT NCT06215612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06215612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ctDNA and MR Imaging Parameters as Possible Biomarkers in Primary Radiochemotherapy of Head and Neck Squamous Cell Carcinomas
Lead sponsor
Franziska Eckert
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 29, 2024
Completion date
February 28, 2030
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, squamous, head and neck neoplasms